Skip to main content
VCbacked
Log inGet Started

Cardior Pharmaceuticals

Hanover, Germany

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

$75.3M raised
Aug 2021
Series B
BiopharmaBiotechnologyPharmaceutical

Top Investors

HTGF (High-Tech Gruenderfonds)Bristol-Myers SquibbInkefEQT Life SciencesSunstone Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cardior Pharmaceuticals

How much funding has Cardior Pharmaceuticals raised?
Cardior Pharmaceuticals has raised $75.3M in total funding. The most recent round was Series B. The last funding was announced in August 2021.
Who are Cardior Pharmaceuticals's investors?
Cardior Pharmaceuticals's investors include HTGF (High-Tech Gruenderfonds), Bristol-Myers Squibb, Inkef, EQT Life Sciences, Sunstone Partners.
Where is Cardior Pharmaceuticals headquartered?
Cardior Pharmaceuticals is headquartered in Hanover, Germany.
What does Cardior Pharmaceuticals do?
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
What stage is Cardior Pharmaceuticals at?
Cardior Pharmaceuticals is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cardior Pharmaceuticals — Funding & Investors." VCBacked, August 25, 2021, https://www.vcbacked.co/company/cardior-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2021). Cardior Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cardior-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Cardior Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cardior-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M